Abstract CT141: A phase 1 trial of RTX-240, an allogeneic engineered red blood cell with cell -surface expression of 4-1BBL and trans-presented IL-15, in patients with advanced sol... von Hamid, Omid, Luke, Jason, Spira, Alexander, Kuesters, Geoffrey M., Sienczylo, Iga, Gordon, Gilad, Johnson, Melissa L.

Volltext

A Phase 1 Study of Two Investigational Agents, ACTR087, an Autologous T Cell Product Expressing an Antibody-Coupled T Cell Receptor, in Combination with SEA-BCMA, a Novel Non-Fucos... von Benson, Don M., Holmes, Houston, Hari, Parameswaran, Sachs, Jessica, Exter, Ben, Ranger, Ann, Cheema, Tooba, Sienczylo, Iga, O'Meara, Megan M., Sussman, Django, Akard, Luke P.

Volltext

Abstract CT187: Phase 1 Trial of RTX-240, allogeneic red blood cells engineered to express 4-1BBL and trans-presented IL-15, in patients (Pts) with advanced solid tumors von Hamid, Omid, Johnson, Melissa L., Luke, Jason, Maziarz, Richard T., Merchan, Jamie, Lim, Emerson E., Patel, Sandip P., Kuesters, Geoffrey M., Sienczylo, Iga, Gordon, Gilad, Campbell, Karen, Horton, Kristin, Turka, Laurence, Spira, Alexander I.

Volltext